Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study-Reference-Cited by-同舟云学术

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Published:2012-04 Issue:9825 Volume:379 Page:1508-1516
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Castaigne Sylvie,Pautas Cécile,Terré Christine,Raffoux Emmanuel,Bordessoule Dominique,Bastie Jean-Noel,Legrand Ollivier,Thomas Xavier,Turlure Pascal,Reman Oumedaly,de Revel Thierry,Gastaud Lauris,de Gunzburg Noémie,Contentin Nathalie,Henry Estelle,Marolleau Jean-Pierre,Aljijakli Ahmad,Rousselot Philippe,Fenaux Pierre,Preudhomme Claude,Chevret Sylvie,Dombret Hervé

Publisher

Elsevier BV

Subject

General Medicine

Reference27 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Döhner;Blood,2010

2. Optimal induction and post-remission therapy for AML in first remission;Rowe;Hematology Am Soc Hematol Educ Program,2009

3. Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics;Hinman;Cancer Res,1993

4. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse;Sievers;J Clin Oncol,2001

5. Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project;McKoy;Leuk Res,2007

Cited by 832 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer;Cancers;2024-09-04

2. Discovery of a potent CDKs/FLT3 PROTAC with enhanced differentiation and proliferation inhibition for AML;European Journal of Medicinal Chemistry;2024-09

3. Immune‐dysregulation harnessing in myeloid neoplasms;Cancer Medicine;2024-09

4. Successful Treatment of Very Severe Sinusoidal Obstruction Syndrome After Gemtuzumab Ozogamicin With Transjugular Intrahepatic Portosystemic Shunt, Defibrotide, and High-Dose Corticosteroids: A Case Report;Cureus;2024-08-24

5. Breaking Boundaries: Immunotherapy for Myeloid Malignancies;Cancers;2024-08-06